Epilepsy and Seizures

This systematic review and meta-analysis compares data for women with and without epilepsy to investigate maternal, fetal, and neonatal complications and their associations with epilepsy and use of antiseizure medications.

This case report describes a patient with status epilepticus and neuroimaging features of fleeting T2 fluid-attenuated inversion recovery hyperintense lesions on magnetic resonance imaging.

This case-control study investigates the risk factors, comorbidities, and prodromal symptoms associated with a diagnosis of Parkinson disease in a large representative database.

This case-control study investigates the association between antiepileptic drugs and incident Parkinson disease.

This Viewpoint discusses unmet therapeutic needs among patients with epilepsy and evaluates the trajectory of treatment development.

This cohort study assesses whether the use of angiotensin receptor blocker therapy is associated with a reduced incidence of epilepsy in patients with hypertension.

This cross-sectional study investigates if genetic diagnoses in patients with epilepsy are associated with changes in clinical management and subsequent outcomes.

This cohort study uses nationwide register data from 3 Nordic countries to examine the association between risk of childhood cancer and high-dose folic acid supplementation in mothers with epilepsy.

This cohort study tests a deep learning model using readily available clinical information to predict treatment success with the first antiseizure medication for individual patients.

This cohort study evaluates associations between mortality and health care utilization among US veterans with drug-resistant epilepsy.

This narrative review presents the most current evidence supporting focal cooling in epilepsy and offers a brief overview of the technical challenges related to focal cooling in humans, including the optimal device design and cooling parameters.

This cohort study evaluates whether children exposed prenatally to antiseizure medications in mono- and duotherapy have increased risk of neurodevelopmental disorders.